Vanda Pharmaceuticals
VNDA
#8786
Rank
โ‚น21.69 B
Marketcap
โ‚น358.80
Share price
6.41%
Change (1 day)
-8.41%
Change (1 year)

EPS for Vanda Pharmaceuticals (VNDA)

EPS in 2023 (TTM): โ‚น22.20

According to Vanda Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -โ‚น434.88. In 2022 the company made an earnings per share (EPS) of โ‚น11.27 a decrease over its 2021 EPS that were of โ‚น56.36.

EPS history for Vanda Pharmaceuticals from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น22.2097%
2022โ‚น11.27-80%
2021โ‚น56.3639.53%
2020โ‚น40.39-80.18%
2019โ‚น203.82334%
2018โ‚น46.96-247.06%
2017-โ‚น31.94-19.05%
2016-โ‚น39.45-55.32%
2015-โ‚น88.29-347.37%
2014โ‚น35.69-156.72%
2013-โ‚น62.93-31.63%
2012-โ‚น92.05172.22%
2011-โ‚น33.81-238.46%
2010โ‚น24.42-119.7%
2009-โ‚น123.98-31.61%
2008-โ‚น181.28-31.32%
2007-โ‚น263.94-99.27%
2006-โ‚น36,39936045.14%
2005-โ‚น100.70

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น627.87-244.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น493.12-213.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น71.38-116.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,899-766.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น93.24-121.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น424.55-197.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-โ‚น412.34-5.18%๐Ÿ‡บ๐Ÿ‡ธ USA